Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Comprehensive Program for Hereditary Transthyretin Amyloidosis

NCT07213297 is registered in ClinicalTrials.gov with Hospital de Alta Complejidad en Red as lead sponsor.

NCT NCT07213297
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07213297 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Comprehensive Program for Hereditary Transthyretin Amyloidosis
Lead sponsor
Hospital de Alta Complejidad en Red
Phase
Observational
Overall status
Recruiting
Start date
November 1, 2025
Completion date
December 1, 2028
Enrollment
20 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

amyloidosis in transthyretin (ttr), amyloidosis, familial